Moneycontrol PRO
HomeNewsCoronavirus treatment

Coronavirus Treatment

Jump to
  • Common OCD drug may be used in early treatment for COVID-19, say scientists

    According to the scientists, fluvoxamine, which is typically used to treat patients with OCD, has strong anti-inflammatory properties, which may help prevent the body's inflammatory reaction to the novel coronavirus.

  • Coronavirus India | Delhi bats for plasma therapy despite ICMR downplaying its efficacy as COVID-19 cure

    Coronavirus India | Delhi bats for plasma therapy despite ICMR downplaying its efficacy as COVID-19 cure

    A trial was earlier conducted by the ICMR across 39 hospitals in the country to find out if plasma therapy COVID-19 fatality or slows the progression of the disease.

  • COVID-19: This 1970s drug prevents novel coronavirus from damaging lungs

    COVID-19: This 1970s drug prevents novel coronavirus from damaging lungs

    Aviptadil is usually used to treat erectile dysfunction in men and Geneva-based pharma company Relief Therapeutics Holdings AG RFLB.S holds a patent for the proprietary drug formulation.

  • Coronavirus pandemic | In West Bengal, COVID-19 test price fixed at Rs 2,250, treatment cost capped in private hospitals

    Coronavirus pandemic | In West Bengal, COVID-19 test price fixed at Rs 2,250, treatment cost capped in private hospitals

    Following the footsteps of Delhi and Maharashtra, the Bengal government also issued a formal advisory to all private hospitals to regulate treatment costs.

  • Coronavirus pandemic | Maharashtra govt bans Patanjali’s COVID-19 medicine Coronil

    Coronavirus pandemic | Maharashtra govt bans Patanjali’s COVID-19 medicine Coronil

    The Rajasthan government has already banned the sale of Patanjali's Coronil until it gets the AYUSH ministry's nod

  • Tamil Nadu government wants to expand use of Siddha for COVID-19 treatment

    Tamil Nadu government wants to expand use of Siddha for COVID-19 treatment

    Upholding how centuries of wisdom has shaped Siddha, Tamil Nadu Development Minister K Pandiarajan has argued that adopting the “unscientific” treatment method would not put the lives of patients at risk.

  • India’s largest COVID-19 facility in Delhi to have 10 times the capacity of China's biggest centre

    India’s largest COVID-19 facility in Delhi to have 10 times the capacity of China's biggest centre

    The deadline to make the first 2,000 of the 10,200 beds available at Delhi's new COVID-19 facility is June 25. The remaining beds are likely to be arranged by July 3

  • Coronavirus outbreak | IRDAI’s new standard COVID-19 health cover may be priced between Rs 600 and Rs 3,000

    Coronavirus outbreak | IRDAI’s new standard COVID-19 health cover may be priced between Rs 600 and Rs 3,000

    The new insurance policy for COVID-19 would cover hospitalisation cost and include a benefit component whereby the amount would be paid immediately upon a novel coronavirus infection being detected.

  • Big Story | Cipla, Hetero get regulator nod for Remdesivir: What this means for COVID-19 patients

    Big Story | Cipla, Hetero get regulator nod for Remdesivir: What this means for COVID-19 patients

    Remdesivir has emerged as one of the most promising drug candidates in the treatment of COVID-19

  • Coronavirus pandemic | India will continue HCQ treatment for mild COVID-19 cases

    Coronavirus pandemic | India will continue HCQ treatment for mild COVID-19 cases

    Health ministry officials, Indian Council of Medical Research (ICMR) experts, and the Drug Controller General of India have collectively reviewed the novel coronavirus clinical management protocol and decided to limit HCQ use to moderate patients.

  • Coronavirus pandemic | 1,500 ventilators produced by Maruti Suzuki ready for dispatch

    Coronavirus pandemic | 1,500 ventilators produced by Maruti Suzuki ready for dispatch

    Maruti Suzuki Chairman RC Bhargava informed that Gujarat and Haryana state governments and Medanta Hospital in Gurugram have already requested supply of ventilators

  • Coronavirus pandemic | Plasma therapy comes to the rescue of a Delhi-based COVID-19 patient

    Coronavirus pandemic | Plasma therapy comes to the rescue of a Delhi-based COVID-19 patient

    The 49-year-old, who is still undergoing treatment at Max Hospital, has been taken off ventilator support.

  • 3 Point Analysis | Why is plasma therapy a beacon of hope in finding COVID-19 cure?

    3 Point Analysis | Why is plasma therapy a beacon of hope in finding COVID-19 cure?

    Moneycontrol's Sakshi Batra does a 3 point analysis of the plasma therapy that is being looked at as a beacon of hope.

  • Coronavirus pandemic | Soon, India to start human clinical trials of ayurvedic drugs to treat COVID-19

    Coronavirus pandemic | Soon, India to start human clinical trials of ayurvedic drugs to treat COVID-19

    Prime Minister Narendra Modi has also been exhorting the citizens of India to fall back on traditional home remedies during times of such global health crisis to boost their immunity

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347